Valid publication:
Morris GN, Winter J, Cato EP, Ritchie AE, Bokkenheuser VD. Clostridium scindens sp. nov., a human intestinal bacterium with desmolytic activity on corticoids. Int. J. Syst. Bacteriol. 1985; 35:478-481.
Nomenclatural status:
validly published under the ICNP
Taxonomic status:
correct name
Risk group:
1
Notes:
😷 The risk group for Canada has been imported on 2024-02-27. The full classification is: risk group = 1, note = "Animal classification RG: 1 - Security sensitive biological agent: No - Terrestrial animal pathogen under Canadian Food Inspection Agency authority: No - Containment level: Containment Level 1". — The risk group for Swiss Confederation has been imported on 2024-02-01. The full classification is: risk group = 1. — The risk group for Germany has been imported on 2023-10-29. The full classification is: risk group = 1.
🎓 Name mentioned 79 times in PubMed until 2024-03-27.
🧍 According to Ludwig et al. (2021), this "species is susceptible to being reclassified among Lachnospiraceae and as a new combination with Extibacter or as a new genus".Publication:
Ludwig W, Viver T, Westram R, Francisco Gago J, Bustos-Caparros E, Knittel K, Amann R, Rossello-Mora R. Release LTP_12_2020, featuring a new ARB alignment and improved 16S rRNA tree for prokaryotic type strains. Syst Appl Microbiol 2021; 44:126218.